Literature DB >> 9074574

Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis.

D P Brandjes1, H R Büller, H Heijboer, M V Huisman, M de Rijk, H Jagt, J W ten Cate.   

Abstract

BACKGROUND: Post-thrombotic syndrome varies from mild oedema to incapacitating swelling with pain and ulceration. We investigated the rate of post-thrombotic syndrome after a first episode of deep-vein thrombosis and assessed the preventive effect of direct application of a sized-to-fit graded compression stocking.
METHODS: Patients with a first episode of venogram-proven proximal deep-vein thrombosis were randomly assigned no stockings (the control group) or made-to-measure graded compression elastic stockings for at least 2 years. Post-thrombotic syndrome was assessed with a standard scoring system that combined clinical characteristics and objective leg measurements. Patients were assessed every 3 months during the first 2 years, and every 6 months thereafter for at least 5 years. The cumulative incidence of mild-to-moderate post-thrombotic syndrome was the primary outcome measure.
FINDINGS: Of the 315 consecutive outpatients considered for inclusion, 44 were excluded and 77 did not consent to take part. 194 patients were randomly assigned compression stockings (n = 96) or no stockings (n = 98). The median follow-up was 76 months (range 60-96) in both groups. Mild-to-moderate post-thrombotic syndrome (score > or = 3 plus one clinical sign) occurred in 19 (20%) patients in the stocking group and in 46 (47%) control-group patients (p < 0.001). 11 (11%) patients in the stocking group developed severe post-thrombotic syndrome (score > or = 4), compared with 23 (23%) patients in the control group (p < 0.001). In both groups, most cases of post-thrombotic syndrome occurred within 24 months of the acute thrombotic event.
INTERPRETATION: About 60% of patients with a first episode of proximal deep-vein thrombosis develop post-thrombotic syndrome within 2 years. A sized-to-fit compression stocking reduced this rate by about 50%.

Entities:  

Mesh:

Year:  1997        PMID: 9074574     DOI: 10.1016/S0140-6736(96)12215-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  99 in total

Review 1.  Preventing thromboembolic complications in older orthopaedic surgery patients: interventions and outcomes.

Authors:  J W Eikelboom; J S Ginsberg
Journal:  Drugs Aging       Date:  1999-10       Impact factor: 3.923

2.  Impact of venous thromboembolism, venous stasis syndrome, venous outflow obstruction and venous valvular incompetence on quality of life and activities of daily living: a nested case-control study.

Authors:  Aneel A Ashrani; Marc D Silverstein; Thom W Rooke; Brian D Lahr; Tanya M Petterson; Kent R Bailey; L Joseph Melton; John A Heit
Journal:  Vasc Med       Date:  2010-10       Impact factor: 3.239

Review 3.  Diagnosis, investigation, and management of deep vein thrombosis.

Authors:  Clive Tovey; Suzanne Wyatt
Journal:  BMJ       Date:  2003-05-31

Review 4.  [Emergencies in phlebology].

Authors:  F Pannier; E Rabe
Journal:  Hautarzt       Date:  2004-06       Impact factor: 0.751

5.  Diagnosis and management of iliofemoral deep vein thrombosis: clinical practice guideline.

Authors:  David Liu; Erica Peterson; James Dooner; Mark Baerlocher; Leslie Zypchen; Joel Gagnon; Michael Delorme; Chad Kim Sing; Jason Wong; Randolph Guzman; Gavin Greenfield; Otto Moodley; Paul Yenson
Journal:  CMAJ       Date:  2015-09-28       Impact factor: 8.262

6.  Deep Venous Thrombosis: Early Discharge Strategies and Outpatient Management.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 7.  [Contrast-enhanced diagnostics in orthopaedics].

Authors:  D Proschek; M Mack; K Kafchitsas; G Fusshoeller; K Hochmuth
Journal:  Orthopade       Date:  2006-06       Impact factor: 1.087

Review 8.  Medical Treatment for Postthrombotic Syndrome.

Authors:  Federico Silva Palacios; Suman Wasan Rathbun
Journal:  Semin Intervent Radiol       Date:  2017-03       Impact factor: 1.513

9.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

10.  Cost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis.

Authors:  T Enden; S Resch; C White; H S Wik; N E Kløw; P M Sandset
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.